{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:35:03Z","timestamp":1787765703895,"version":"build-2784847793"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871260"],"award-info":[{"award-number":["81871260"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Young Scholars Fostering Fund of the First Affiliated Hospital of Nanjing Medical University","award":["PY2022007"],"award-info":[{"award-number":["PY2022007"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Hepatocellular carcinoma (HCC) is one of the most prevalent cancers worldwide and a major public health challenge. Lipid metabolism plays a crucial role in the metabolic reprogramming observed in HCC, although the underlying mechanisms are still being elucidated. Nile red staining and lipid assays showed that LRP11 knockdown significantly reduces lipid accumulation in HCC cells, with a concurrent decrease in key lipid metabolism markers such as FSAN, ACLY and ACSL4, as demonstrated by Western blotting. Mass spectrometry (MS) and co-immunoprecipitation (Co-IP) revealed that LRP11 recruits USP5, enhancing USP5-mediated deubiquitination of RACK1. Truncation analysis identified LRP11 residues 309\u2013500 as critical for interaction with the RACK1 residues 91\u2013231. These findings suggest that LRP11 may influence lipid metabolism and progression in HCC through USP5-mediated stabilization of RACK1. Based on these results, LRP11 emerges as a potential target for further exploration in HCC therapy. Targeting LRP11 or disrupting its interactions with USP5 or RACK1 could offer new avenues for treatment, though additional research is required to validate these therapeutic possibilities.<\/jats:p>","DOI":"10.1186\/s10020-025-01097-6","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T15:48:06Z","timestamp":1738338486000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["LRP11 facilitates lipid metabolism and malignancy in hepatocellular carcinoma by stabilizing RACK1 through USP5 regulation"],"prefix":"10.1186","volume":"31","author":[{"given":"Litao","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deming","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingpeng","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianbao","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhou","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,31]]},"reference":[{"key":"1097_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/cells8050512","author":"N Berndt","year":"2019","unstructured":"Berndt N, Eckstein J, Heucke N, Gajowski R, Stockmann M, Meierhofer D, et al. Characterization of lipid and lipid droplet metabolism in human HCC. Cells. 2019. https:\/\/doi.org\/10.3390\/cells8050512.","journal-title":"Cells"},{"key":"1097_CR2","doi-asserted-by":"publisher","first-page":"811","DOI":"10.7150\/thno.29271","volume":"9","author":"J Cao","year":"2019","unstructured":"Cao J, Zhao M, Liu J, Zhang X, Pei Y, Wang J, et al. RACK1 promotes self-renewal and chemoresistance of cancer stem cells in human hepatocellular carcinoma through stabilizing nanog. Theranostics. 2019;9:811\u201328. https:\/\/doi.org\/10.7150\/thno.29271.","journal-title":"Theranostics"},{"key":"1097_CR3","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1002\/1878-0261.12644","volume":"14","author":"H Dan","year":"2020","unstructured":"Dan H, Liu S, Liu J, Liu D, Yin F, Wei Z, et al. RACK1 promotes cancer progression by increasing the M2\/M1 macrophage ratio via the NF-\u03baB pathway in oral squamous cell carcinoma. Mol Oncol. 2020;14:795\u2013807. https:\/\/doi.org\/10.1002\/1878-0261.12644.","journal-title":"Mol Oncol"},{"key":"1097_CR4","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1053\/j.gastro.2011.12.046","volume":"142","author":"YZ Deng","year":"2012","unstructured":"Deng YZ, Yao F, Li JJ, Mao ZF, Hu PT, Long LY, et al. RACK1 suppresses gastric tumorigenesis by stabilizing the \u03b2-catenin destruction complex. Gastroenterology. 2012;142:812-823.e815. https:\/\/doi.org\/10.1053\/j.gastro.2011.12.046.","journal-title":"Gastroenterology"},{"key":"1097_CR5","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.jhep.2018.02.003","volume":"68","author":"F Duan","year":"2018","unstructured":"Duan F, Wu H, Jia D, Wu W, Ren S, Wang L, et al. O-GlcNAcylation of RACK1 promotes hepatocellular carcinogenesis. J Hepatol. 2018;68:1191\u2013202. https:\/\/doi.org\/10.1016\/j.jhep.2018.02.003.","journal-title":"J Hepatol"},{"key":"1097_CR6","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.cellsig.2017.03.005","volume":"35","author":"D Duff","year":"2017","unstructured":"Duff D, Long A. Roles for RACK1 in cancer cell migration and invasion. Cell Signal. 2017;35:250\u20135. https:\/\/doi.org\/10.1016\/j.cellsig.2017.03.005.","journal-title":"Cell Signal"},{"key":"1097_CR7","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1080\/1061186x.2019.1687710","volume":"28","author":"S Gan","year":"2020","unstructured":"Gan S, Ye J, Li J, Hu C, Wang J, Xu D, et al. LRP11 activates \u03b2-catenin to induce PD-L1 expression in prostate cancer. J Drug Target. 2020;28:508\u201315. https:\/\/doi.org\/10.1080\/1061186x.2019.1687710.","journal-title":"J Drug Target"},{"key":"1097_CR8","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000033201","volume":"102","author":"F Gu","year":"2023","unstructured":"Gu F, Xu F, Pan Z, Shi L, Yu J, Song F, et al. An integrative pan-cancer analysis illustrating the key role of LRP11 in cervical cancer. Medicine (Baltimore). 2023;102: e33201. https:\/\/doi.org\/10.1097\/md.0000000000033201.","journal-title":"Medicine (Baltimore)"},{"key":"1097_CR9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12964-023-01060-0","volume":"21","author":"L He","year":"2023","unstructured":"He L, Guo Z, Wang W, Tian S, Lin R. FUT2 inhibits the EMT and metastasis of colorectal cancer by increasing LRP1 fucosylation. Cell Commun Signal. 2023;21:63. https:\/\/doi.org\/10.1186\/s12964-023-01060-0.","journal-title":"Cell Commun Signal"},{"key":"1097_CR10","doi-asserted-by":"publisher","first-page":"156","DOI":"10.2174\/1389450115666141224125117","volume":"16","author":"AD Khwairakpam","year":"2015","unstructured":"Khwairakpam AD, Shyamananda MS, Sailo BL, Rathnakaram SR, Padmavathi G, Kotoky J, et al. ATP citrate lyase (ACLY): a promising target for cancer prevention and treatment. Curr Drug Targets. 2015;16:156\u201363. https:\/\/doi.org\/10.2174\/1389450115666141224125117.","journal-title":"Curr Drug Targets"},{"key":"1097_CR11","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1038\/onc.2014.127","volume":"34","author":"JJ Li","year":"2015","unstructured":"Li JJ, Xie D. RACK1, a versatile hub in cancer. Oncogene. 2015;34:1890\u20138. https:\/\/doi.org\/10.1038\/onc.2014.127.","journal-title":"Oncogene"},{"key":"1097_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2023.110835","volume":"110","author":"Y Li","year":"2023","unstructured":"Li Y, Li R, Qin H, He H, Li S. OTUB1\u2019s role in promoting OSCC development by stabilizing RACK1 involves cell proliferation, migration, invasion, and tumor-associated macrophage M1 polarization. Cell Signal. 2023;110: 110835. https:\/\/doi.org\/10.1016\/j.cellsig.2023.110835.","journal-title":"Cell Signal"},{"key":"1097_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216807","volume":"593","author":"H Lin","year":"2024","unstructured":"Lin H, Fu L, Zhou X, Yu A, Chen Y, Liao W, et al. LRP1 induces anti-PD-1 resistance by modulating the DLL4-NOTCH2-CCL2 axis and redirecting M2-like macrophage polarisation in bladder cancer. Cancer Lett. 2024;593: 216807. https:\/\/doi.org\/10.1016\/j.canlet.2024.216807.","journal-title":"Cancer Lett"},{"key":"1097_CR14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41413-021-00152-2","volume":"9","author":"S Liu","year":"2021","unstructured":"Liu S, Wu D, Sun X, Fan Y, Zha R, Jalali A, et al. Overexpression of Lrp5 enhanced the anti-breast cancer effects of osteocytes in bone. Bone Res. 2021;9:32. https:\/\/doi.org\/10.1038\/s41413-021-00152-2.","journal-title":"Bone Res"},{"key":"1097_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2024.04.002","author":"B Liu","year":"2024","unstructured":"Liu B, Bukhari I, Li F, Ren F, Xia X, Hu B, et al. Enhanced LRP8 expression induced by Helicobacter pylori drives gastric cancer progression by facilitating \u03b2-Catenin nuclear translocation. J Adv Res. 2024. https:\/\/doi.org\/10.1016\/j.jare.2024.04.002.","journal-title":"J Adv Res"},{"key":"1097_CR16","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular Carcinoma. Nat Rev Dis Primers. 2021;7:6. https:\/\/doi.org\/10.1038\/s41572-020-00240-3.","journal-title":"Nat Rev Dis Primers"},{"key":"1097_CR17","first-page":"27","volume":"13","author":"G Medes","year":"1953","unstructured":"Medes G, Thomas A, Weinhouse S. Metabolism of neoplastic tissue. IV. A study of lipid synthesis in neoplastic tissue slices in vitro. Cancer Res. 1953;13:27\u20139.","journal-title":"Cancer Res"},{"key":"1097_CR18","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/nrc2222","volume":"7","author":"JA Menendez","year":"2007","unstructured":"Menendez JA, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer. 2007;7:763\u201377. https:\/\/doi.org\/10.1038\/nrc2222.","journal-title":"Nat Rev Cancer"},{"key":"1097_CR19","doi-asserted-by":"publisher","first-page":"573","DOI":"10.7150\/thno.27654","volume":"9","author":"J Meng","year":"2019","unstructured":"Meng J, Ai X, Lei Y, Zhong W, Qian B, Qiao K, et al. USP5 promotes epithelial-mesenchymal transition by stabilizing SLUG in hepatocellular carcinoma. Theranostics. 2019;9:573\u201387. https:\/\/doi.org\/10.7150\/thno.27654.","journal-title":"Theranostics"},{"key":"1097_CR20","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.1111\/cas.15519","volume":"113","author":"H Ou","year":"2022","unstructured":"Ou H, Wang L, Xi Z, Shen H, Jiang Y, Zhou F, et al. MYO10 contributes to the malignant phenotypes of colorectal cancer via RACK1 by activating integrin\/Src\/FAK signaling. Cancer Sci. 2022;113:3838\u201351. https:\/\/doi.org\/10.1111\/cas.15519.","journal-title":"Cancer Sci"},{"key":"1097_CR21","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s13402-023-00913-7","volume":"47","author":"L Peng","year":"2024","unstructured":"Peng L, Wu T, Liu Y, Zhao D, He W, Yuan Y. OTUB1 accelerates hepatocellular carcinoma by stabilizing RACK1 via its non-canonical ubiquitination. Cell Oncol (Dordr). 2024;47:987\u20131004. https:\/\/doi.org\/10.1007\/s13402-023-00913-7.","journal-title":"Cell Oncol (Dordr)"},{"key":"1097_CR22","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1038\/s41418-023-01226-w","volume":"30","author":"Y Pi","year":"2023","unstructured":"Pi Y, Feng Q, Sun F, Wang Z, Zhao Y, Chen D, et al. Loss of SMURF2 expression enhances RACK1 stability and promotes ovarian cancer progression. Cell Death Differ. 2023;30:2382\u201392. https:\/\/doi.org\/10.1038\/s41418-023-01226-w.","journal-title":"Cell Death Differ"},{"key":"1097_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174397","volume":"909","author":"J Quan","year":"2021","unstructured":"Quan J, Bode AM, Luo X. ACSL family: The regulatory mechanisms and therapeutic implications in cancer. Eur J Pharmacol. 2021;909: 174397. https:\/\/doi.org\/10.1016\/j.ejphar.2021.174397.","journal-title":"Eur J Pharmacol"},{"key":"1097_CR24","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1038\/s41388-022-02259-0","volume":"41","author":"Z Rong","year":"2022","unstructured":"Rong Z, Zhang L, Li Z, Xiao Z, Duan Y, Ren X, et al. SIK2 maintains breast cancer stemness by phosphorylating LRP6 and activating Wnt\/\u03b2-catenin signaling. Oncogene. 2022;41:2390\u2013403. https:\/\/doi.org\/10.1038\/s41388-022-02259-0.","journal-title":"Oncogene"},{"key":"1097_CR25","doi-asserted-by":"publisher","first-page":"4536302","DOI":"10.1155\/2019\/4536302","volume":"2019","author":"Z Roslan","year":"2019","unstructured":"Roslan Z, Muhamad M, Selvaratnam L, Ab-Rahim S. The roles of low-density lipoprotein receptor-related proteins 5, 6, and 8 in cancer: a review. J Oncol. 2019;2019:4536302. https:\/\/doi.org\/10.1155\/2019\/4536302.","journal-title":"J Oncol"},{"key":"1097_CR26","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/nrd.2017.179","volume":"16","author":"M Schapira","year":"2017","unstructured":"Schapira M, Tyers M, Torrent M, Arrowsmith CH. WD40 repeat domain proteins: a novel target class? Nat Rev Drug Discov. 2017;16:773\u201386. https:\/\/doi.org\/10.1038\/nrd.2017.179.","journal-title":"Nat Rev Drug Discov"},{"key":"1097_CR27","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"key":"1097_CR28","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41419-023-06191-3","volume":"14","author":"R Tian","year":"2023","unstructured":"Tian R, Tian J, Zuo X, Ren S, Zhang H, Liu H, et al. RACK1 facilitates breast cancer progression by competitively inhibiting the binding of \u03b2-catenin to PSMD2 and enhancing the stability of \u03b2-catenin. Cell Death Dis. 2023;14:685. https:\/\/doi.org\/10.1038\/s41419-023-06191-3.","journal-title":"Cell Death Dis"},{"key":"1097_CR29","doi-asserted-by":"publisher","first-page":"515","DOI":"10.2741\/s82","volume":"2","author":"C Wang","year":"2010","unstructured":"Wang C, Rajput S, Watabe K, Liao DF, Cao D. Acetyl-CoA carboxylase-a as a novel target for cancer therapy. Front Biosci (Schol Ed). 2010;2:515\u201326. https:\/\/doi.org\/10.2741\/s82.","journal-title":"Front Biosci (Schol Ed)"},{"key":"1097_CR30","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12964-021-00818-8","volume":"20","author":"A Wang","year":"2022","unstructured":"Wang A, Yang W, Li Y, Zhang Y, Zhou J, Zhang R, et al. CPNE1 promotes non-small cell lung cancer progression by interacting with RACK1 via the MET signaling pathway. Cell Commun Signal. 2022;20:16. https:\/\/doi.org\/10.1186\/s12964-021-00818-8.","journal-title":"Cell Commun Signal"},{"key":"1097_CR31","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/s41392-023-01405-8","volume":"8","author":"W Wei","year":"2023","unstructured":"Wei W, Qin B, Wen W, Zhang B, Luo H, Wang Y, et al. FBXW7\u03b2 loss-of-function enhances FASN-mediated lipogenesis and promotes colorectal cancer growth. Signal Transduct Target Ther. 2023;8:187. https:\/\/doi.org\/10.1038\/s41392-023-01405-8.","journal-title":"Signal Transduct Target Ther"},{"key":"1097_CR32","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.canlet.2019.11.002","volume":"469","author":"H Wu","year":"2020","unstructured":"Wu H, Song S, Yan A, Guo X, Chang L, Xu L, et al. RACK1 promotes the invasive activities and lymph node metastasis of cervical cancer via galectin-1. Cancer Lett. 2020;469:287\u2013300. https:\/\/doi.org\/10.1016\/j.canlet.2019.11.002.","journal-title":"Cancer Lett"},{"key":"1097_CR33","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/s41419-023-06048-9","volume":"14","author":"K Xia","year":"2023","unstructured":"Xia K, Zheng D, Wei Z, Liu W, Guo W. TRIM26 inhibited osteosarcoma progression through destabilizing RACK1 and thus inactivation of MEK\/ERK signaling. Cell Death Dis. 2023;14:529. https:\/\/doi.org\/10.1038\/s41419-023-06048-9.","journal-title":"Cell Death Dis"},{"key":"1097_CR34","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1038\/s41419-018-1113-9","volume":"9","author":"T Xiao","year":"2018","unstructured":"Xiao T, Zhu W, Huang W, Lu SS, Li XH, Xiao ZQ, et al. RACK1 promotes tumorigenicity of colon cancer by inducing cell autophagy. Cell Death Dis. 2018;9:1148. https:\/\/doi.org\/10.1038\/s41419-018-1113-9.","journal-title":"Cell Death Dis"},{"key":"1097_CR35","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1038\/s41467-023-38605-3","volume":"14","author":"X Xiao","year":"2023","unstructured":"Xiao X, Shi J, He C, Bu X, Sun Y, Gao M, et al. ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy. Nat Commun. 2023;14:2859. https:\/\/doi.org\/10.1038\/s41467-023-38605-3.","journal-title":"Nat Commun"},{"key":"1097_CR36","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/s41388-020-01572-w","volume":"40","author":"Z Yu","year":"2021","unstructured":"Yu Z, Jiang X, Qin L, Deng H, Wang J, Ren W, et al. A novel UBE2T inhibitor suppresses Wnt\/\u03b2-catenin signaling hyperactivation and gastric cancer progression by blocking RACK1 ubiquitination. Oncogene. 2021;40:1027\u201342. https:\/\/doi.org\/10.1038\/s41388-020-01572-w.","journal-title":"Oncogene"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-025-01097-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-025-01097-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-025-01097-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T15:48:10Z","timestamp":1738338490000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-025-01097-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,31]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1097"],"URL":"https:\/\/doi.org\/10.1186\/s10020-025-01097-6","relation":{},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,31]]},"assertion":[{"value":"21 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the First Affiliated Hospital of Nanjing Medical University. Informed consent was obtained from all patients in compliance with regional regulations. All animal experiments in this study were approved by the Institutional Animal Care and Use Committee of the First Affiliated Hospital of Nanjing Medical University (IACUC-2406029).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35"}}